nodes	percent_of_prediction	percent_of_DWPC	metapath
Testolactone—Erythema—Tolbutamide—type 2 diabetes mellitus	0.013	0.017	CcSEcCtD
Testolactone—Blood pressure increased—Gliclazide—type 2 diabetes mellitus	0.0124	0.0162	CcSEcCtD
Testolactone—Erythema—Tolazamide—type 2 diabetes mellitus	0.0118	0.0155	CcSEcCtD
Testolactone—Blood pressure increased—Valsartan—type 2 diabetes mellitus	0.0114	0.0149	CcSEcCtD
Testolactone—Erythema—Acarbose—type 2 diabetes mellitus	0.0114	0.0149	CcSEcCtD
Testolactone—Ill-defined disorder—Tolazamide—type 2 diabetes mellitus	0.011	0.0144	CcSEcCtD
Testolactone—Malaise—Tolazamide—type 2 diabetes mellitus	0.0107	0.0139	CcSEcCtD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYB5R4—type 2 diabetes mellitus	0.0103	0.0568	CbGpPWpGaD
Testolactone—Discomfort—Tolazamide—type 2 diabetes mellitus	0.00994	0.013	CcSEcCtD
Testolactone—Blood pressure increased—Irbesartan—type 2 diabetes mellitus	0.00979	0.0128	CcSEcCtD
Testolactone—Alopecia—Repaglinide—type 2 diabetes mellitus	0.00962	0.0126	CcSEcCtD
Testolactone—Erythema—Repaglinide—type 2 diabetes mellitus	0.00948	0.0124	CcSEcCtD
Testolactone—Oedema—Acarbose—type 2 diabetes mellitus	0.00927	0.0121	CcSEcCtD
Testolactone—CYP19A1—Tryptophan metabolism—AANAT—type 2 diabetes mellitus	0.00923	0.0508	CbGpPWpGaD
Testolactone—Anorexia—Chlorpropamide—type 2 diabetes mellitus	0.00919	0.012	CcSEcCtD
Testolactone—CYP19A1—Metabolism of steroid hormones and vitamin D—SRD5A1—type 2 diabetes mellitus	0.00865	0.0476	CbGpPWpGaD
Testolactone—Glossitis—Ramipril—type 2 diabetes mellitus	0.00857	0.0112	CcSEcCtD
Testolactone—Decreased appetite—Chlorpropamide—type 2 diabetes mellitus	0.00838	0.011	CcSEcCtD
Testolactone—CYP19A1—Metabolism of steroid hormones and vitamin D—STAR—type 2 diabetes mellitus	0.00825	0.0454	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of steroid hormones and vitamin D—HSD17B3—type 2 diabetes mellitus	0.00825	0.0454	CbGpPWpGaD
Testolactone—Feeling abnormal—Tolazamide—type 2 diabetes mellitus	0.00795	0.0104	CcSEcCtD
Testolactone—Erythema—Glipizide—type 2 diabetes mellitus	0.00784	0.0103	CcSEcCtD
Testolactone—Oedema—Repaglinide—type 2 diabetes mellitus	0.00773	0.0101	CcSEcCtD
Testolactone—CYP19A1—Metabolism of steroid hormones and vitamin D—HSD11B1—type 2 diabetes mellitus	0.00735	0.0404	CbGpPWpGaD
Testolactone—Erythema—Glimepiride—type 2 diabetes mellitus	0.00732	0.00958	CcSEcCtD
Testolactone—Oedema—Rosiglitazone—type 2 diabetes mellitus	0.00731	0.00957	CcSEcCtD
Testolactone—Ill-defined disorder—Glipizide—type 2 diabetes mellitus	0.00727	0.00952	CcSEcCtD
Testolactone—Malaise—Glipizide—type 2 diabetes mellitus	0.00707	0.00925	CcSEcCtD
Testolactone—Nausea—Miglitol—type 2 diabetes mellitus	0.007	0.00917	CcSEcCtD
Testolactone—Ill-defined disorder—Pioglitazone—type 2 diabetes mellitus	0.00697	0.00912	CcSEcCtD
Testolactone—Paraesthesia—Repaglinide—type 2 diabetes mellitus	0.00694	0.00909	CcSEcCtD
Testolactone—Malaise—Pioglitazone—type 2 diabetes mellitus	0.00677	0.00886	CcSEcCtD
Testolactone—Ill-defined disorder—Sitagliptin—type 2 diabetes mellitus	0.00677	0.00886	CcSEcCtD
Testolactone—Alopecia—Bromocriptine—type 2 diabetes mellitus	0.0067	0.00877	CcSEcCtD
Testolactone—Discomfort—Glipizide—type 2 diabetes mellitus	0.0066	0.00863	CcSEcCtD
Testolactone—CYP19A1—Endogenous sterols—CYP11A1—type 2 diabetes mellitus	0.00659	0.0362	CbGpPWpGaD
Testolactone—Malaise—Sitagliptin—type 2 diabetes mellitus	0.00658	0.00861	CcSEcCtD
Testolactone—Oedema—Glipizide—type 2 diabetes mellitus	0.0064	0.00837	CcSEcCtD
Testolactone—Discomfort—Pioglitazone—type 2 diabetes mellitus	0.00632	0.00827	CcSEcCtD
Testolactone—Nausea—Tolbutamide—type 2 diabetes mellitus	0.0063	0.00824	CcSEcCtD
Testolactone—CYP19A1—Metabolism of steroid hormones and vitamin D—HSD3B2—type 2 diabetes mellitus	0.00625	0.0344	CbGpPWpGaD
Testolactone—Discomfort—Sitagliptin—type 2 diabetes mellitus	0.00614	0.00803	CcSEcCtD
Testolactone—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00613	0.00803	CcSEcCtD
Testolactone—Oedema—Pioglitazone—type 2 diabetes mellitus	0.00613	0.00802	CcSEcCtD
Testolactone—Alopecia—Glyburide—type 2 diabetes mellitus	0.00613	0.00802	CcSEcCtD
Testolactone—Anorexia—Glipizide—type 2 diabetes mellitus	0.0061	0.00798	CcSEcCtD
Testolactone—Erythema—Glyburide—type 2 diabetes mellitus	0.00603	0.0079	CcSEcCtD
Testolactone—Vomiting—Acarbose—type 2 diabetes mellitus	0.00589	0.00771	CcSEcCtD
Testolactone—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.00575	0.00752	CcSEcCtD
Testolactone—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00573	0.0075	CcSEcCtD
Testolactone—Nausea—Tolazamide—type 2 diabetes mellitus	0.00573	0.0075	CcSEcCtD
Testolactone—Anorexia—Glimepiride—type 2 diabetes mellitus	0.00569	0.00745	CcSEcCtD
Testolactone—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00568	0.00744	CcSEcCtD
Testolactone—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.00556	0.00728	CcSEcCtD
Testolactone—Nausea—Acarbose—type 2 diabetes mellitus	0.0055	0.0072	CcSEcCtD
Testolactone—Pain—Glipizide—type 2 diabetes mellitus	0.00547	0.00716	CcSEcCtD
Testolactone—Erythema—Gliclazide—type 2 diabetes mellitus	0.00542	0.00709	CcSEcCtD
Testolactone—Oedema—Bromocriptine—type 2 diabetes mellitus	0.00539	0.00705	CcSEcCtD
Testolactone—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.00536	0.00702	CcSEcCtD
Testolactone—Prednisone—HSD11B1—type 2 diabetes mellitus	0.00535	0.0988	CrCbGaD
Testolactone—Nausea—Nateglinide—type 2 diabetes mellitus	0.00531	0.00695	CcSEcCtD
Testolactone—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.00527	0.0069	CcSEcCtD
Testolactone—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.00519	0.00679	CcSEcCtD
Testolactone—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.00517	0.00677	CcSEcCtD
Testolactone—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.00514	0.00672	CcSEcCtD
Testolactone—Pain—Sitagliptin—type 2 diabetes mellitus	0.00509	0.00666	CcSEcCtD
Testolactone—Alopecia—Valsartan—type 2 diabetes mellitus	0.00505	0.00661	CcSEcCtD
Testolactone—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00505	0.00661	CcSEcCtD
Testolactone—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.00503	0.00658	CcSEcCtD
Testolactone—Alopecia—Orlistat—type 2 diabetes mellitus	0.00499	0.00653	CcSEcCtD
Testolactone—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—type 2 diabetes mellitus	0.00493	0.0272	CbGpPWpGaD
Testolactone—Oedema—Glyburide—type 2 diabetes mellitus	0.00492	0.00645	CcSEcCtD
Testolactone—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.00492	0.00644	CcSEcCtD
Testolactone—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00492	0.00644	CcSEcCtD
Testolactone—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.00491	0.00642	CcSEcCtD
Testolactone—Malaise—Gliclazide—type 2 diabetes mellitus	0.00489	0.00639	CcSEcCtD
Testolactone—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.00484	0.00633	CcSEcCtD
Testolactone—Anorexia—Glyburide—type 2 diabetes mellitus	0.00469	0.00614	CcSEcCtD
Testolactone—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.00468	0.00613	CcSEcCtD
Testolactone—Nausea—Repaglinide—type 2 diabetes mellitus	0.00459	0.00601	CcSEcCtD
Testolactone—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.00456	0.00597	CcSEcCtD
Testolactone—Discomfort—Gliclazide—type 2 diabetes mellitus	0.00456	0.00596	CcSEcCtD
Testolactone—Erythema—Metformin—type 2 diabetes mellitus	0.00453	0.00593	CcSEcCtD
Testolactone—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00444	0.00581	CcSEcCtD
Testolactone—Malaise—Orlistat—type 2 diabetes mellitus	0.00444	0.00581	CcSEcCtD
Testolactone—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.00442	0.00579	CcSEcCtD
Testolactone—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00434	0.00568	CcSEcCtD
Testolactone—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.00428	0.0056	CcSEcCtD
Testolactone—Erythema—Irbesartan—type 2 diabetes mellitus	0.00428	0.0056	CcSEcCtD
Testolactone—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.00421	0.0055	CcSEcCtD
Testolactone—Discomfort—Orlistat—type 2 diabetes mellitus	0.00414	0.00542	CcSEcCtD
Testolactone—Malaise—Metformin—type 2 diabetes mellitus	0.00409	0.00535	CcSEcCtD
Testolactone—Alopecia—Losartan—type 2 diabetes mellitus	0.00409	0.00535	CcSEcCtD
Testolactone—Vomiting—Glipizide—type 2 diabetes mellitus	0.00407	0.00532	CcSEcCtD
Testolactone—Oedema—Valsartan—type 2 diabetes mellitus	0.00406	0.00532	CcSEcCtD
Testolactone—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00406	0.00531	CcSEcCtD
Testolactone—Erythema—Losartan—type 2 diabetes mellitus	0.00403	0.00527	CcSEcCtD
Testolactone—Oedema—Orlistat—type 2 diabetes mellitus	0.00401	0.00525	CcSEcCtD
Testolactone—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00397	0.0052	CcSEcCtD
Testolactone—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.00397	0.00519	CcSEcCtD
Testolactone—Anorexia—Valsartan—type 2 diabetes mellitus	0.00387	0.00507	CcSEcCtD
Testolactone—Malaise—Irbesartan—type 2 diabetes mellitus	0.00386	0.00505	CcSEcCtD
Testolactone—Discomfort—Metformin—type 2 diabetes mellitus	0.00381	0.00499	CcSEcCtD
Testolactone—Nausea—Glipizide—type 2 diabetes mellitus	0.0038	0.00497	CcSEcCtD
Testolactone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.0038	0.00497	CcSEcCtD
Testolactone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00378	0.00495	CcSEcCtD
Testolactone—Pain—Gliclazide—type 2 diabetes mellitus	0.00378	0.00495	CcSEcCtD
Testolactone—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.00374	0.00489	CcSEcCtD
Testolactone—CYP19A1—Ovarian Infertility Genes—CCND2—type 2 diabetes mellitus	0.00372	0.0205	CbGpPWpGaD
Testolactone—Oedema—Metformin—type 2 diabetes mellitus	0.0037	0.00484	CcSEcCtD
Testolactone—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00365	0.00477	CcSEcCtD
Testolactone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00364	0.00477	CcSEcCtD
Testolactone—Malaise—Losartan—type 2 diabetes mellitus	0.00363	0.00475	CcSEcCtD
Testolactone—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.0036	0.00472	CcSEcCtD
Testolactone—Discomfort—Irbesartan—type 2 diabetes mellitus	0.0036	0.00471	CcSEcCtD
Testolactone—Nausea—Glimepiride—type 2 diabetes mellitus	0.00355	0.00464	CcSEcCtD
Testolactone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00354	0.00463	CcSEcCtD
Testolactone—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00353	0.00462	CcSEcCtD
Testolactone—Anorexia—Metformin—type 2 diabetes mellitus	0.00353	0.00462	CcSEcCtD
Testolactone—Alopecia—Ramipril—type 2 diabetes mellitus	0.0035	0.00459	CcSEcCtD
Testolactone—Oedema—Irbesartan—type 2 diabetes mellitus	0.00349	0.00457	CcSEcCtD
Testolactone—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00349	0.00457	CcSEcCtD
Testolactone—Erythema—Ramipril—type 2 diabetes mellitus	0.00345	0.00452	CcSEcCtD
Testolactone—Pain—Orlistat—type 2 diabetes mellitus	0.00343	0.00449	CcSEcCtD
Testolactone—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00343	0.00448	CcSEcCtD
Testolactone—Discomfort—Losartan—type 2 diabetes mellitus	0.00339	0.00443	CcSEcCtD
Testolactone—Anorexia—Irbesartan—type 2 diabetes mellitus	0.00333	0.00436	CcSEcCtD
Testolactone—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00332	0.00435	CcSEcCtD
Testolactone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00331	0.00433	CcSEcCtD
Testolactone—Oedema—Losartan—type 2 diabetes mellitus	0.00329	0.0043	CcSEcCtD
Testolactone—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00322	0.00421	CcSEcCtD
Testolactone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.0032	0.00419	CcSEcCtD
Testolactone—Nausea—Bromocriptine—type 2 diabetes mellitus	0.0032	0.00419	CcSEcCtD
Testolactone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00314	0.0041	CcSEcCtD
Testolactone—Anorexia—Losartan—type 2 diabetes mellitus	0.00313	0.0041	CcSEcCtD
Testolactone—Vomiting—Glyburide—type 2 diabetes mellitus	0.00313	0.0041	CcSEcCtD
Testolactone—CYP19A1—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	0.00312	0.0172	CbGpPWpGaD
Testolactone—Malaise—Ramipril—type 2 diabetes mellitus	0.00311	0.00407	CcSEcCtD
Testolactone—CYP19A1—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	0.00309	0.017	CbGpPWpGaD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	0.00306	0.0168	CbGpPWpGaD
Testolactone—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00305	0.00399	CcSEcCtD
Testolactone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.00304	0.00397	CcSEcCtD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	0.00302	0.0166	CbGpPWpGaD
Testolactone—CYP19A1—Tryptophan metabolism—CYP3A4—type 2 diabetes mellitus	0.00301	0.0166	CbGpPWpGaD
Testolactone—Pain—Irbesartan—type 2 diabetes mellitus	0.00299	0.00391	CcSEcCtD
Testolactone—Paraesthesia—Losartan—type 2 diabetes mellitus	0.00295	0.00386	CcSEcCtD
Testolactone—Nausea—Glyburide—type 2 diabetes mellitus	0.00293	0.00383	CcSEcCtD
Testolactone—Discomfort—Ramipril—type 2 diabetes mellitus	0.0029	0.0038	CcSEcCtD
Testolactone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.00288	0.00377	CcSEcCtD
Testolactone—Decreased appetite—Losartan—type 2 diabetes mellitus	0.00286	0.00374	CcSEcCtD
Testolactone—Oedema—Ramipril—type 2 diabetes mellitus	0.00282	0.00369	CcSEcCtD
Testolactone—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00281	0.00368	CcSEcCtD
Testolactone—Pain—Losartan—type 2 diabetes mellitus	0.00281	0.00368	CcSEcCtD
Testolactone—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00271	0.00354	CcSEcCtD
Testolactone—Anorexia—Ramipril—type 2 diabetes mellitus	0.00269	0.00351	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—MAT1A—type 2 diabetes mellitus	0.00268	0.0148	CbGpPWpGaD
Testolactone—Nausea—Gliclazide—type 2 diabetes mellitus	0.00263	0.00344	CcSEcCtD
Testolactone—Vomiting—Valsartan—type 2 diabetes mellitus	0.00258	0.00338	CcSEcCtD
Testolactone—Vomiting—Orlistat—type 2 diabetes mellitus	0.00255	0.00334	CcSEcCtD
Testolactone—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.00253	0.00331	CcSEcCtD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	0.00252	0.0139	CbGpPWpGaD
Testolactone—CYP19A1—Tryptophan metabolism—CAT—type 2 diabetes mellitus	0.00251	0.0138	CbGpPWpGaD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	0.0025	0.0137	CbGpPWpGaD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	0.00249	0.0137	CbGpPWpGaD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	0.00248	0.0136	CbGpPWpGaD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	0.00246	0.0136	CbGpPWpGaD
Testolactone—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.00245	0.00321	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—type 2 diabetes mellitus	0.00244	0.0134	CbGpPWpGaD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP3A4—type 2 diabetes mellitus	0.00243	0.0134	CbGpPWpGaD
Testolactone—Nausea—Valsartan—type 2 diabetes mellitus	0.00241	0.00316	CcSEcCtD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP3A4—type 2 diabetes mellitus	0.0024	0.0132	CbGpPWpGaD
Testolactone—Nausea—Orlistat—type 2 diabetes mellitus	0.00238	0.00312	CcSEcCtD
Testolactone—Vomiting—Metformin—type 2 diabetes mellitus	0.00235	0.00308	CcSEcCtD
Testolactone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00232	0.00304	CcSEcCtD
Testolactone—Danazol—CCL2—type 2 diabetes mellitus	0.00227	0.0419	CrCbGaD
Testolactone—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00222	0.00291	CcSEcCtD
Testolactone—Nausea—Metformin—type 2 diabetes mellitus	0.0022	0.00288	CcSEcCtD
Testolactone—Vomiting—Losartan—type 2 diabetes mellitus	0.00209	0.00273	CcSEcCtD
Testolactone—Nausea—Irbesartan—type 2 diabetes mellitus	0.00207	0.00271	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	0.00205	0.0113	CbGpPWpGaD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	0.00202	0.0111	CbGpPWpGaD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	0.00197	0.0109	CbGpPWpGaD
Testolactone—Nausea—Losartan—type 2 diabetes mellitus	0.00195	0.00255	CcSEcCtD
Testolactone—Vomiting—Ramipril—type 2 diabetes mellitus	0.00179	0.00234	CcSEcCtD
Testolactone—Nausea—Ramipril—type 2 diabetes mellitus	0.00167	0.00219	CcSEcCtD
Testolactone—CYP19A1—FSH signaling pathway—SRC—type 2 diabetes mellitus	0.00165	0.00909	CbGpPWpGaD
Testolactone—Prednicarbate—NR3C1—type 2 diabetes mellitus	0.0016	0.0295	CrCbGaD
Testolactone—Drospirenone—AR—type 2 diabetes mellitus	0.00153	0.0282	CrCbGaD
Testolactone—Desonide—NR3C1—type 2 diabetes mellitus	0.00151	0.0279	CrCbGaD
Testolactone—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.00147	0.0272	CrCbGaD
Testolactone—Loteprednol—NR3C1—type 2 diabetes mellitus	0.00146	0.0269	CrCbGaD
Testolactone—CYP19A1—Biological oxidations—MTR—type 2 diabetes mellitus	0.00136	0.00748	CbGpPWpGaD
Testolactone—Fluoxymesterone—SHBG—type 2 diabetes mellitus	0.00135	0.025	CrCbGaD
Testolactone—CYP19A1—Biological oxidations—CYP11A1—type 2 diabetes mellitus	0.00132	0.00725	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	0.0013	0.00715	CbGpPWpGaD
Testolactone—Danazol—SHBG—type 2 diabetes mellitus	0.00129	0.0239	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—HMGCR—type 2 diabetes mellitus	0.00128	0.00706	CbGpPWpGaD
Testolactone—Testosterone Propionate—AR—type 2 diabetes mellitus	0.00128	0.0236	CrCbGaD
Testolactone—Spironolactone—SHBG—type 2 diabetes mellitus	0.00124	0.0229	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.00123	0.00679	CbGpPWpGaD
Testolactone—Fluoxymesterone—AR—type 2 diabetes mellitus	0.00119	0.0219	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	0.00117	0.00643	CbGpPWpGaD
Testolactone—Budesonide—NR3C1—type 2 diabetes mellitus	0.00116	0.0214	CrCbGaD
Testolactone—Danazol—AR—type 2 diabetes mellitus	0.00113	0.0209	CrCbGaD
Testolactone—Mometasone—NR3C1—type 2 diabetes mellitus	0.0011	0.0204	CrCbGaD
Testolactone—Methyltestosterone—SHBG—type 2 diabetes mellitus	0.00109	0.0202	CrCbGaD
Testolactone—Rimexolone—NR3C1—type 2 diabetes mellitus	0.00109	0.0201	CrCbGaD
Testolactone—CYP19A1—Biological oxidations—CYP2E1—type 2 diabetes mellitus	0.00109	0.00598	CbGpPWpGaD
Testolactone—Spironolactone—AR—type 2 diabetes mellitus	0.00109	0.02	CrCbGaD
Testolactone—CYP19A1—Biological oxidations—CYP1A2—type 2 diabetes mellitus	0.00108	0.00592	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	0.00107	0.0059	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	0.00106	0.00583	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—CYP3A4—type 2 diabetes mellitus	0.00105	0.00577	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—AR—type 2 diabetes mellitus	0.00105	0.00576	CbGpPWpGaD
Testolactone—Estrone—SHBG—type 2 diabetes mellitus	0.00104	0.0192	CrCbGaD
Testolactone—CYP19A1—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	0.00103	0.00569	CbGpPWpGaD
Testolactone—CYP19A1—FSH signaling pathway—AKT1—type 2 diabetes mellitus	0.00103	0.00565	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—type 2 diabetes mellitus	0.000995	0.00548	CbGpPWpGaD
Testolactone—Exemestane—CYP3A4—type 2 diabetes mellitus	0.000971	0.0179	CrCbGaD
Testolactone—Spironolactone—ABCC2—type 2 diabetes mellitus	0.000966	0.0178	CrCbGaD
Testolactone—Methyltestosterone—AR—type 2 diabetes mellitus	0.000958	0.0177	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.000954	0.00525	CbGpPWpGaD
Testolactone—Ciclesonide—NR3C1—type 2 diabetes mellitus	0.000946	0.0175	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	0.000909	0.005	CbGpPWpGaD
Testolactone—Methylprednisolone—NR3C1—type 2 diabetes mellitus	0.000907	0.0168	CrCbGaD
Testolactone—Testosterone—CYP11A1—type 2 diabetes mellitus	0.000899	0.0166	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	0.000886	0.00488	CbGpPWpGaD
Testolactone—Dexamethasone—CYP11A1—type 2 diabetes mellitus	0.00087	0.0161	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	0.000845	0.00465	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	0.000845	0.00465	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	0.000845	0.00465	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—GSTM1—type 2 diabetes mellitus	0.000824	0.00453	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	0.000813	0.00447	CbGpPWpGaD
Testolactone—Fluoxymesterone—NR3C1—type 2 diabetes mellitus	0.000804	0.0149	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MMP1—type 2 diabetes mellitus	0.000778	0.00428	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	0.000766	0.00422	CbGpPWpGaD
Testolactone—Triamcinolone—NR3C1—type 2 diabetes mellitus	0.000765	0.0141	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	0.000753	0.00415	CbGpPWpGaD
Testolactone—Spironolactone—NR3C1—type 2 diabetes mellitus	0.000737	0.0136	CrCbGaD
Testolactone—Dexamethasone—NOS2—type 2 diabetes mellitus	0.000721	0.0133	CrCbGaD
Testolactone—Prednisone—NR3C1—type 2 diabetes mellitus	0.000694	0.0128	CrCbGaD
Testolactone—Budesonide—CYP3A4—type 2 diabetes mellitus	0.000673	0.0124	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—IRS1—type 2 diabetes mellitus	0.000671	0.00369	CbGpPWpGaD
Testolactone—Progesterone—SHBG—type 2 diabetes mellitus	0.00067	0.0124	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	0.000641	0.00353	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	0.000641	0.00353	CbGpPWpGaD
Testolactone—Prednisolone—NR3C1—type 2 diabetes mellitus	0.00064	0.0118	CrCbGaD
Testolactone—Testosterone—SHBG—type 2 diabetes mellitus	0.000634	0.0117	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000632	0.00348	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—BHMT—type 2 diabetes mellitus	0.000628	0.00346	CbGpPWpGaD
Testolactone—Betamethasone—NR3C1—type 2 diabetes mellitus	0.000627	0.0116	CrCbGaD
Testolactone—Progesterone—AR—type 2 diabetes mellitus	0.000588	0.0108	CrCbGaD
Testolactone—Drospirenone—PTGS2—type 2 diabetes mellitus	0.000587	0.0108	CrCbGaD
Testolactone—Estrone—CYP2E1—type 2 diabetes mellitus	0.00057	0.0105	CrCbGaD
Testolactone—Testosterone—AR—type 2 diabetes mellitus	0.000556	0.0103	CrCbGaD
Testolactone—CYP19A1—Metabolism—PTGDS—type 2 diabetes mellitus	0.000549	0.00302	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—AANAT—type 2 diabetes mellitus	0.000549	0.00302	CbGpPWpGaD
Testolactone—Ciclesonide—CYP3A4—type 2 diabetes mellitus	0.000548	0.0101	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000543	0.00299	CbGpPWpGaD
Testolactone—Estrone—CYP1A2—type 2 diabetes mellitus	0.000543	0.01	CrCbGaD
Testolactone—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	0.000526	0.00971	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	0.000522	0.00287	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CDO1—type 2 diabetes mellitus	0.000521	0.00287	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GPD2—type 2 diabetes mellitus	0.000521	0.00287	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	0.000509	0.0028	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	0.000506	0.00278	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—AK1—type 2 diabetes mellitus	0.000497	0.00273	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	0.000491	0.0027	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—type 2 diabetes mellitus	0.000479	0.00263	CbGpPWpGaD
Testolactone—Dexamethasone—ABCC2—type 2 diabetes mellitus	0.000478	0.00883	CrCbGaD
Testolactone—CYP19A1—Metabolism—MAT1A—type 2 diabetes mellitus	0.000458	0.00252	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000458	0.00252	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	0.000456	0.00251	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	0.000448	0.00247	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000447	0.00246	CbGpPWpGaD
Testolactone—Danazol—CYP3A4—type 2 diabetes mellitus	0.000446	0.00823	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	0.000444	0.00244	CbGpPWpGaD
Testolactone—Triamcinolone—CYP3A4—type 2 diabetes mellitus	0.000444	0.00819	CrCbGaD
Testolactone—CYP19A1—Metabolism—ND1—type 2 diabetes mellitus	0.000443	0.00244	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ENPP1—type 2 diabetes mellitus	0.000443	0.00244	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000443	0.00244	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HBA2—type 2 diabetes mellitus	0.000443	0.00244	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—G6PC—type 2 diabetes mellitus	0.000443	0.00244	CbGpPWpGaD
Testolactone—Triamcinolone—PTGS2—type 2 diabetes mellitus	0.000434	0.00802	CrCbGaD
Testolactone—CYP19A1—Metabolism—GCGR—type 2 diabetes mellitus	0.000429	0.00236	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	0.000413	0.00227	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.000406	0.00223	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—OXCT1—type 2 diabetes mellitus	0.000405	0.00223	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYTB—type 2 diabetes mellitus	0.000405	0.00223	CbGpPWpGaD
Testolactone—Prednisone—CYP3A4—type 2 diabetes mellitus	0.000402	0.00743	CrCbGaD
Testolactone—Progesterone—NR3C1—type 2 diabetes mellitus	0.000399	0.00736	CrCbGaD
Testolactone—CYP19A1—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000395	0.00217	CbGpPWpGaD
Testolactone—Methyltestosterone—CYP3A4—type 2 diabetes mellitus	0.000377	0.00695	CrCbGaD
Testolactone—CYP19A1—Metabolism—ACACA—type 2 diabetes mellitus	0.000376	0.00207	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000376	0.00207	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—STAR—type 2 diabetes mellitus	0.000376	0.00207	CbGpPWpGaD
Testolactone—Prednisolone—CYP3A4—type 2 diabetes mellitus	0.000371	0.00685	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	0.000365	0.00201	CbGpPWpGaD
Testolactone—Dexamethasone—NR3C1—type 2 diabetes mellitus	0.000365	0.00673	CrCbGaD
Testolactone—Betamethasone—CYP3A4—type 2 diabetes mellitus	0.000363	0.00671	CrCbGaD
Testolactone—CYP19A1—Metabolism—ABCC8—type 2 diabetes mellitus	0.000361	0.00199	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CBS—type 2 diabetes mellitus	0.000361	0.00199	CbGpPWpGaD
Testolactone—Estrone—CYP3A4—type 2 diabetes mellitus	0.000359	0.00663	CrCbGaD
Testolactone—Betamethasone—PTGS2—type 2 diabetes mellitus	0.000356	0.00657	CrCbGaD
Testolactone—Prednisone—ALB—type 2 diabetes mellitus	0.000351	0.00648	CrCbGaD
Testolactone—Progesterone—CYP1A2—type 2 diabetes mellitus	0.000349	0.00644	CrCbGaD
Testolactone—CYP19A1—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000347	0.00191	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—COX2—type 2 diabetes mellitus	0.000347	0.00191	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NCOA6—type 2 diabetes mellitus	0.000341	0.00188	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.000341	0.00188	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—UCP3—type 2 diabetes mellitus	0.000336	0.00185	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—UCP2—type 2 diabetes mellitus	0.000336	0.00185	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000336	0.00185	CbGpPWpGaD
Testolactone—Dexamethasone—CYP2E1—type 2 diabetes mellitus	0.000336	0.00619	CrCbGaD
Testolactone—Methyltestosterone—ALB—type 2 diabetes mellitus	0.000328	0.00606	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	0.000325	0.00179	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PCK1—type 2 diabetes mellitus	0.000315	0.00174	CbGpPWpGaD
Testolactone—Estrone—ALB—type 2 diabetes mellitus	0.000313	0.00578	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	0.000311	0.00171	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	0.000303	0.00167	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HK1—type 2 diabetes mellitus	0.000295	0.00163	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	0.000295	0.00162	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GCKR—type 2 diabetes mellitus	0.000285	0.00157	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000285	0.00157	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—LPA—type 2 diabetes mellitus	0.000285	0.00157	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000285	0.00157	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	0.000274	0.00151	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ALDOB—type 2 diabetes mellitus	0.000274	0.00151	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	0.000266	0.00146	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	0.00026	0.00143	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	0.000259	0.00143	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	0.000257	0.00142	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GLP1R—type 2 diabetes mellitus	0.000254	0.0014	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000237	0.00131	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CPT1A—type 2 diabetes mellitus	0.000233	0.00128	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—MTR—type 2 diabetes mellitus	0.000233	0.00128	CbGpPWpGaD
Testolactone—Progesterone—CYP3A4—type 2 diabetes mellitus	0.000231	0.00427	CrCbGaD
Testolactone—CYP19A1—Metabolism—NAMPT—type 2 diabetes mellitus	0.000228	0.00126	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	0.000227	0.00125	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HBA1—type 2 diabetes mellitus	0.000227	0.00125	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GCK—type 2 diabetes mellitus	0.000227	0.00125	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—LIPC—type 2 diabetes mellitus	0.000227	0.00125	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000225	0.00124	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000221	0.00122	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CETP—type 2 diabetes mellitus	0.000219	0.0012	CbGpPWpGaD
Testolactone—Testosterone—CYP3A4—type 2 diabetes mellitus	0.000218	0.00403	CrCbGaD
Testolactone—Dexamethasone—CYP3A4—type 2 diabetes mellitus	0.000211	0.0039	CrCbGaD
Testolactone—Dexamethasone—PTGS2—type 2 diabetes mellitus	0.000207	0.00382	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	0.000204	0.00112	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PSMD6—type 2 diabetes mellitus	0.000203	0.00112	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SNAP25—type 2 diabetes mellitus	0.000203	0.00112	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SREBF1—type 2 diabetes mellitus	0.000203	0.00112	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CTGF—type 2 diabetes mellitus	0.0002	0.0011	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HMGCR—type 2 diabetes mellitus	0.000198	0.00109	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	0.000195	0.00107	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000194	0.00106	CbGpPWpGaD
Testolactone—Testosterone—ALB—type 2 diabetes mellitus	0.000191	0.00352	CrCbGaD
Testolactone—CYP19A1—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000186	0.00102	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000184	0.00101	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000184	0.00101	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000179	0.000987	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	0.000178	0.000982	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000176	0.00097	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GCG—type 2 diabetes mellitus	0.000176	0.00097	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GNB3—type 2 diabetes mellitus	0.000152	0.000836	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000152	0.000836	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HMOX1—type 2 diabetes mellitus	0.000151	0.000832	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CAT—type 2 diabetes mellitus	0.000149	0.000821	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—APOB—type 2 diabetes mellitus	0.000145	0.000797	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTM1—type 2 diabetes mellitus	0.000141	0.000775	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—LPL—type 2 diabetes mellitus	0.000138	0.000761	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ADCY5—type 2 diabetes mellitus	0.000135	0.000745	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GPX1—type 2 diabetes mellitus	0.000135	0.000743	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CD36—type 2 diabetes mellitus	0.000131	0.000723	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PPP2CA—type 2 diabetes mellitus	0.00013	0.000714	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—MTHFR—type 2 diabetes mellitus	0.000125	0.000685	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PPARA—type 2 diabetes mellitus	0.000122	0.000672	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—AGT—type 2 diabetes mellitus	0.000118	0.000651	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CALM1—type 2 diabetes mellitus	0.000116	0.00064	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—APOE—type 2 diabetes mellitus	0.000116	0.000638	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—APOA1—type 2 diabetes mellitus	0.000115	0.000631	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PPARG—type 2 diabetes mellitus	0.000101	0.000556	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—INS—type 2 diabetes mellitus	9.9e-05	0.000545	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ALB—type 2 diabetes mellitus	9.08e-05	0.0005	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	8.69e-05	0.000478	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NOS3—type 2 diabetes mellitus	8.69e-05	0.000478	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PTGS2—type 2 diabetes mellitus	7.94e-05	0.000437	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	3.99e-05	0.00022	CbGpPWpGaD
